Exposed group for Epidural Analgesia

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Canada
Epidural AnalgesiaEducational tool about epidural analgesia - Other
Eligibility

Study Summary

This trial is being done to see if an educational tool can help improve a person's understanding of the risks and benefits of epidural anesthesia, and if it leads to better informed consent about the procedure.

Eligible Conditions
  • Epidural Analgesia

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Post-partum day 1

Post-partum day 1
Analgesia, Epidural

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Control Group
1 of 2
Exposed group
1 of 2

Active Control

126 Total Participants · 2 Treatment Groups

Primary Treatment: Exposed group · No Placebo Group · N/A

Control GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:
Exposed group
Other
ActiveComparator Group · 1 Intervention: Educational tool about epidural analgesia · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: post-partum day 1

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
274 Previous Clinical Trials
68,251 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any available vacancies for prospective participants in this experiment?

"Per the clinicaltrials.gov platform, this trial is actively enrolling patients and was initially posted on June 15th 2021 with its most recent update being April 29th 2022." - Anonymous Online Contributor

Unverified Answer

How many people are taking part in this clinical assessment?

"Affirmative. The information on clinicaltrials.gov indicates that this experiment is in the process of seeking participants and was initially made available on June 15th 2021. Subsequently, it has been modified as recently as April 29th 2022, with a requirement for 126 individuals at one site to be enrolled." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.